SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-08-000018
Filing Date
2008-01-08
Accepted
2008-01-08 09:54:54
Documents
4
Period of Report
2007-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k18875.htm 6-K 17237
2 Q2 INTERIM FINANCIAL STATEMENTS FOR PERIOD ENDED NOVEMBER 30, 2007 ex991.htm EX-99.1 724009
3 Q2 MANAGEMENT'S DISCUSSION AND ANALYSIS ex992.htm EX-99.2 189779
4 Q2 CEO / CFO CERTIFICATIONS ex993.htm EX-99.3 25460
  Complete submission text file 0001279569-08-000018.txt   958118
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 08516748
SIC: 2836 Biological Products, (No Diagnostic Substances)